Tower Research Capital LLC (TRC)
Position in GALT — Galectin Therapeutics Inc
CIK 1533421
NEW YORK, NY
Position in GALT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,303
-$12,711 QoQ
Shares Held
4,410
-26.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $67,724,931 across 440 Biotechnology names. GALT ranks #270 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
12,112 | $8,844,787 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,904 | $6,208,692 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,378 | $3,382,617 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,627 | $3,185,285 | |
| 5 | INSM |
INSMED Inc
|
15,410 | $2,519,843 | |
| 6 | LKFT |
Lakefront Biotherapeutics NV
|
66,536 | $1,996,080 | |
| 7 | MRNA |
Moderna, Inc.
|
33,728 | $1,713,382 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
14,349 | $1,065,556 |
All Filings in GALT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,303 | 4,410 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,014 | 6,013 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $10,168 | 4,819 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,086 | 6,628 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,833 | 7,623 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,978 | 3,265 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,006 | 4,428 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,429 | 5,619 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,229 | 7,367 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,835 | 13,456 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,491 | 8,675 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,059 | 6,219 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $13,696 | 12,121 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $12,030 | 7,381 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $9,365 | 7,150 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $3,939 | 2,447 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $19,431 | 9,387 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,923 | 3,073 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $32,646 | 10,202 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,988 | 5,064 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $37,352 | 16,675 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $114,452 | 42,866 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $26,199 | 8,562 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,192 | 2,139 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||